The American College of Radiology and others say paying physicians less for interpreting multiple, same-day imaging exams will shift more business to pricier hospitals and hurt access to care.
Medscape Medical News
Avastin is no longer FDA approved for breast cancer. This decision was upheld at a hearing last week. Eye patients, however, need not worry.
The Food and Drug Administration had removed its approval for Avastin for the treatment of breast cancer last December. A hearing last week (June, 2011) allowed Genentech and the drugs’ supporters, to voice their concerns about the removal of the drug.